Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 7 Pharmacology PhD Projects, Programmes & Scholarships in Liverpool
Pharmacology PhD Projects, Programmes & Scholarships in Liverpool
We have 7 Pharmacology PhD Projects, Programmes & Scholarships in Liverpool
PhD saved successfully
Determining the role of mitochondrial DNA variation in hepatic pathways and its impact on physiology, pharmacology and toxicology: a combined in vitro and bioinformatic approach.
Project Background and Aims. It is widely known that differences in the nuclear genome contribute to aspects of us as individuals, from hair colour to lifespan. Read more
Assessment of matrix metalloproteinase 9 inhibitor for the treatment of severe skin-blistering adverse drug reactions using in vitro and ex vivo skin models.
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, immune-related, severe skin-blistering reactions which can be caused by a wide range of commonly administered drugs. SJS/TEN is characterised by wide-spread skin (epidermal) detachment and recent work in our lab has identified a number of potential molecular mechanism by which this could occur. Read more
Interaction between innate immune activation and endothelial cells, linked to adverse cardiovascular events
The complement system is a key component of the immune response. Maintaining a balance between activation and inhibition of the complement system is key to preserving tissue homeostasis and enabling immune surveillance. Read more
Molecular characterisation of a novel transporter for the atypical antipsychotic clozapine
Schizophrenia is a severe psychiatric illness affecting about 24 million people worldwide. Schizophrenia can have a devastating effect on a patient’s life and is associated with increased mortality, with life expectancy reduced on average by 15 years compared to that of the general population. Read more
Personalising cancer treatment with modelling tumour evolution based on genomics biomarkers and PK/PD
Tumour heterogeneity is a major problem limiting the efficacy of targeted oncological therapies. Most advanced tumours eventually become resistant to the treatments, ultimately making the patient succumb to metastatic disease. Read more
Determining the biocompatibility of, novel, nano-silica coated surfaces on oral and gastrointestinal immune barriers
The interaction of nanoparticles with cells, particularly those that are immune-competent, may affect their biocompatibility, particularly when applied in long-term situations. Read more
A systems biology analysis of thioredoxin reductase inhibition to support discovery of a novel antifungal treatment
Fungal diseases affect approximately 1.2 billion individuals worldwide with at least 1.5 million deaths each year. The emergence of resistant strains made clinical treatment failures more frequent. Read more
- 1